Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Biologic complexity in sickle cell disease: implications for developing targeted therapeutics.

Gee BE.

ScientificWorldJournal. 2013 Mar 25;2013:694146. doi: 10.1155/2013/694146. Print 2013. Review.

2.

Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.

Okam MM, Ebert BL.

Expert Rev Hematol. 2012 Jun;5(3):303-11. doi: 10.1586/ehm.12.20. Review.

PMID:
22780210
3.

Sickle cell disease, vasculopathy, and therapeutics.

Kassim AA, DeBaun MR.

Annu Rev Med. 2013;64:451-66. doi: 10.1146/annurev-med-120611-143127. Epub 2012 Nov 26. Review.

PMID:
23190149
4.

Hematopoietic stem cell transplantation for sickle cell disease: state of the science.

Talano JA, Cairo MS.

Eur J Haematol. 2015 May;94(5):391-9. doi: 10.1111/ejh.12447. Epub 2014 Oct 10. Review.

PMID:
25200500
5.

Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.

Estcourt LJ, Fortin PM, Hopewell S, Trivella M, Wang WC.

Cochrane Database Syst Rev. 2017 Jan 17;1:CD003146. doi: 10.1002/14651858.CD003146.pub3. Review.

PMID:
28094851
6.

Sickle Cell Disease: A Brief Update.

Azar S, Wong TE.

Med Clin North Am. 2017 Mar;101(2):375-393. doi: 10.1016/j.mcna.2016.09.009. Epub 2016 Dec 14. Review.

PMID:
28189177
7.

Oxidative stress in sickle cell disease: an overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies.

Silva DG, Belini Junior E, de Almeida EA, Bonini-Domingos CR.

Free Radic Biol Med. 2013 Dec;65:1101-9. doi: 10.1016/j.freeradbiomed.2013.08.181. Epub 2013 Aug 31. Review.

PMID:
24002011
8.

Sickle cell disease; a general overview.

Schnog JB, Duits AJ, Muskiet FA, ten Cate H, Rojer RA, Brandjes DP.

Neth J Med. 2004 Nov;62(10):364-74. Review.

9.

Sickle cell disease: role of reactive oxygen and nitrogen metabolites.

Wood KC, Granger DN.

Clin Exp Pharmacol Physiol. 2007 Sep;34(9):926-32. Review.

PMID:
17645642
10.

Hemoglobin s polymerization and red cell membrane changes.

Kuypers FA.

Hematol Oncol Clin North Am. 2014 Apr;28(2):155-79. doi: 10.1016/j.hoc.2013.12.002. Epub 2014 Jan 22. Review.

PMID:
24589260
11.

Inflammatory targets of therapy in sickle cell disease.

Owusu-Ansah A, Ihunnah CA, Walker AL, Ofori-Acquah SF.

Transl Res. 2016 Jan;167(1):281-97. doi: 10.1016/j.trsl.2015.07.001. Epub 2015 Jul 11. Review.

12.

Established and experimental treatments for sickle cell disease.

De Franceschi L, Corrocher R.

Haematologica. 2004 Mar;89(3):348-56. Review.

13.

The role of blood rheology in sickle cell disease.

Connes P, Alexy T, Detterich J, Romana M, Hardy-Dessources MD, Ballas SK.

Blood Rev. 2016 Mar;30(2):111-8. doi: 10.1016/j.blre.2015.08.005. Epub 2015 Aug 28. Review.

PMID:
26341565
14.

Developing treatment for sickle cell disease.

Steinberg MH, Brugnara C.

Expert Opin Investig Drugs. 2002 May;11(5):645-59. Review.

PMID:
11996646
15.

Thinking beyond sickling to better understand pain in sickle cell disease.

Darbari DS, Ballas SK, Clauw DJ.

Eur J Haematol. 2014 Aug;93(2):89-95. doi: 10.1111/ejh.12340. Epub 2014 May 16. Review.

16.

Preoperative blood transfusions for sickle cell disease.

Estcourt LJ, Fortin PM, Trivella M, Hopewell S.

Cochrane Database Syst Rev. 2016 Apr 6;4:CD003149. doi: 10.1002/14651858.CD003149.pub3. Review.

17.

Role of Exercise-Induced Oxidative Stress in Sickle Cell Trait and Disease.

Chirico EN, Faƫs C, Connes P, Canet-Soulas E, Martin C, Pialoux V.

Sports Med. 2016 May;46(5):629-39. doi: 10.1007/s40279-015-0447-z. Review.

PMID:
26666745
18.

Leukotriene pathway in sickle cell disease: a potential target for directed therapy.

Knight-Perry J, DeBaun MR, Strunk RC, Field JJ.

Expert Rev Hematol. 2009 Feb;2(1):57-68. doi: 10.1586/17474086.2.1.57. Review.

PMID:
21082995
19.

Thrombosis and sickle cell disease.

De Franceschi L, Cappellini MD, Olivieri O.

Semin Thromb Hemost. 2011 Apr;37(3):226-36. doi: 10.1055/s-0031-1273087. Epub 2011 Mar 31. Review.

PMID:
21455857
20.

The pharmacotherapy of sickle cell disease.

Wang WC.

Expert Opin Pharmacother. 2008 Dec;9(17):3069-82. doi: 10.1517/14656560802519878 . Review.

PMID:
19006479

Supplemental Content

Support Center